AB
Publications
- Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19
- PDGFRα and αSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
- Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach.
- Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner.
- Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases.
- IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis.
- LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
- Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis.
- The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1.
- Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension
- Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia
- Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease
- The vascular perspective on acute and chronic lung disease
- CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis
- Lung Fibrosis Is Linked to Increased Endothelial Cell Activation and Dysfunctional Vascular Barrier Integrity
- Between inflammation and thrombosis: endothelial cells in COVID-19
- Pulmonary vascular remodeling in Fra-2 transgenic mice is driven by type 2 inflammation and accompanied by pulmonary vascular hyperresponsiveness